Attempts to define biological aging: scope, actionability, plurality

There are many ways to define biological/organismal aging, here I collected together 6. They are presented in historical order to show how different topics showed up in them and thinking on aging gained more depth. You should not expect strict definitions in the logical sense with necessary and sufficient conditions but attempts to highlight the […]

World Health Organisation’s new global target & focus on healthy aging

The WHO is under pressure to commit more work and focus on healthy aging. A representative and data-backed call was expressed by the paper published in Aging and Disease, called Aging Health and R&D for Healthy Longevity Must Be Included into the WHO Work Program It looks like the WHO has listened as according to John Beard, Director […]

Launching a limited AgeCurve pilot in the US!

We are finally in a position to run a pilot programme in the US. We are now offering a chance for some curious, early adopter Americans to understand what deep age and deep agings profiling mean according to AgeCurve’s view focusing on proteins via personal proteomics. Please email us over at if interested. Thank you.

Problem or programme: Narratives of old age and the coming Longevity Economy

At AgeCurve we are trying to build a startup culture that is aging-savvy from the ground up. This is not as easy as it sounds as aging is a phenomenon affecting the majority of human activities and domains, so quite an intimidating subject. Also it is not as easy to convince a devops for instance […]

Farewell Gen P, welcome new AgeCurve App

We are getting there! Based on our early user experience interviews, we have re-designed our application. We wanted to reach 2 goals More accessible, less scientific content Focusing clearly on aging related features Accordingly, we have also dropped the name ‘Gen P’ and renamed the application simply to be called AgeCurve App from now on. If […]

Cellular senescence: zombie cells and matrix metalloproteinases

In a recent Quartz piece called The first drugs designed to fight aging are ready for human testing, the journalist W. Harry Fortuna provides an excellent and pictorial description of the important biological process, cellular senescence: Senolytics target a known mechanism of aging, cell senescence. Normally, cells die a “complete” death known as apoptosis. Senescence is […]

Silicon Valley Entrepreneur Daniel Reda joins AgeCurve’s Advisory Board

In July I have announced that Kathryn Lilley is joining our Advisory Board, advising us on science related matters. Today I’m thrilled to announce that Daniel Reda is joining our Board as well, helping us to navigate our small boat with his California trained, biomedical business skills. Daniel and I were colleagues at Singularity University […]

Top 4 ‘getting started’ in aging & healthspan extension resources

During a recent Gen P user experience session one early adopter asked me to provide a reading list to get the user started with digging into understanding aging science and longevity and healthspan extension technologies/scenarios. Here I provide a short subjective list containing different resources suited to a general non-biomedical audience. The list contains 1 scientific […]

Cambridge Proteomicist Kathryn Lilley joins AgeCurve’s Advisory Board

I am thrilled to announce that Professor Kathryn Lilley, of Cambridge University, is joining AgeCurve’s Advisory Board. Kathryn is the director of Cambridge Centre for Proteomics with a deep understanding of mass spectrometry based proteomics. I was privileged to work with Kathryn before and since AgeCurve is a Cambridge-based startup it was rather predictable for […]

AgeCurve Founder’s talk at an SIU event at Cambridge University

AgeCurve’s founder, Attila Csordas is giving a talk at the Meet the Founder: Pitch Perfect event at Cambridge University. The event is organised by The Science Innovation Union, an entrepreneurs-led not-for-profit organization with over 2,500 members across London, Cambridge, Oxford, Frankfurt.